Jia Sheng Tu
Directeur/Membre du Conseil chez SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.
Profil
Jia Sheng Tu currently works at Suzhou Fushilai Pharmaceutical Co., Ltd., as Independent Director from 2022.
Dr. Tu also formerly worked at Jiangsu Lianhuan Pharmaceutical Co., Ltd., as Independent Director and NKD Pharma Co., Ltd., as Independent Director from 2018 to 2022.
Postes actifs de Jia Sheng Tu
Sociétés | Poste | Début |
---|---|---|
SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 09/09/2022 |
Anciens postes connus de Jia Sheng Tu
Sociétés | Poste | Fin |
---|---|---|
JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 27/06/2022 |
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 25/04/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD. | Health Technology |
SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD. | Process Industries |
Entreprise privées | 1 |
---|---|
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |